{"id":"W2777724352","doi":"10.1021/acs.molpharmaceut.7b00843","title":"Ratio-Dependent Synergism of a Doxorubicin and Olaparib Combination in 2D and Spheroid Models of Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"Molecular Pharmaceutics","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"U.S. Army; Natural Sciences and Engineering Research Council of Canada; Ontario Trillium Foundation","keywords":"Olaparib; Ovarian cancer; Serous fluid; Cancer research; PARP inhibitor; Spheroid; Medicine; Paclitaxel; Pharmacology; Doxorubicin; Drug; Cancer; Combination therapy; Poly ADP ribose polymerase; Oncology; Biology; Internal medicine; Chemotherapy; Polymerase; Cell culture; Genetics; DNA","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002394682,0.0001157753,0.0002819601,0.0000823369,0.00004881087,0.0000166241,0.00007872014,0.00007665237,0.00002911259],"category_scores_gemma":[0.00002271103,0.0001195702,0.00002989122,0.0000505867,0.0001714026,0.0001119343,0.00005537476,0.0001520906,2.665538e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005772393,"about_ca_system_score_gemma":0.00008090003,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003109997,"about_ca_topic_score_gemma":0.00003778148,"domain_scores_codex":[0.9990914,0.00005177621,0.0002918728,0.000186366,0.0002442048,0.0001343444],"domain_scores_gemma":[0.9992794,0.00001968231,0.0002310297,0.000282265,0.000107605,0.00008001239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002787032,0.000171845,0.006934823,0.0002501663,0.00009536856,0.00003888983,0.000672369,0.001230582,0.980362,0.004242057,0.0000264991,0.005696712],"study_design_scores_gemma":[0.008218047,0.00009651699,0.005126348,0.0002466107,0.000116747,0.00001793214,0.00005751635,0.04335766,0.940132,0.002335735,0.0001785379,0.0001163706],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9894899,0.003078239,0.004603067,0.001180613,0.00009756853,0.0004162766,0.00002305199,0.000009064046,0.001102266],"genre_scores_gemma":[0.9971408,0.001870581,0.000530228,0.0003193294,0.00001711459,0.00002786537,0.000005415684,0.00001878625,0.00006991888],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04212708,"threshold_uncertainty_score":0.4875931,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05005587452836661,"score_gpt":0.3733061430112517,"score_spread":0.3232502684828851,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}